"Osler's phenomenon": misdiagnosing Cushing's syndrome

P De1, L M Evans, M F Scanlon

  • 1Department of Endocrinology, University of Wales College of Medicine, Cardiff, UK. deyparanab@hotmail.com

Insights

Delayed diagnosis of Cushing's syndrome leads to significant patient harm. Increasing clinical awareness and screening can improve outcomes for this rare but serious condition.

Area of Science:

  • Endocrinology
  • Medical History

Background:

  • Cushing's syndrome presents with variable clinical manifestations, often leading to misdiagnosis and delayed treatment.
  • Harvey Cushing described the syndrome, but Sir William Osler provided the first typical description in 1898.

Observation:

  • Four cases illustrate significant morbidity due to delayed diagnosis of Cushing's syndrome.
  • Despite presenting symptoms, patients experienced delays in diagnosis by primary and secondary care physicians.

Findings:

  • Trans-sphenoidal surgery achieved biochemical cure and improved comorbidities in the presented cases.
  • The prevalence of Cushing's syndrome is increasing, highlighting the need for greater awareness.

Implications:

  • Earlier diagnosis through increased clinical awareness and screening is crucial for reducing morbidity and mortality.
  • The historical context suggests renaming delayed diagnosis of Cushing's syndrome as "Osler's phenomenon" to honor Sir William Osler's contribution.

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...